Genetics of Parkinson Disease and Related Diseases

[1]  A. Destée,et al.  The protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants , 2014, Neurobiology of Aging.

[2]  J. Trojanowski,et al.  Clinical and biochemical differences in patients having Parkinson disease with vs without GBA mutations. , 2013, JAMA neurology.

[3]  R. Saunders-Pullman,et al.  The Association Between ß-Glucocerebrosidase Mutations and Parkinsonism , 2013, Current Neurology and Neuroscience Reports.

[4]  M. Nalls,et al.  A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies. , 2013, JAMA neurology.

[5]  A. Puschmann.  Monogenic Parkinson's disease and parkinsonism: clinical phenotypes and frequencies of known mutations. , 2013, Parkinsonism & related disorders.

[6]  E. Melamed,et al.  DJ-1 protects against dopamine toxicity: implications for Parkinson's disease and aging. , 2013, The journals of gerontology. Series A, Biological sciences and medical sciences.

[7]  Mark Hallett,et al.  Criteria for the diagnosis of corticobasal degeneration , 2013, Neurology.

[8]  H. Rana,et al.  Age-specific Parkinson disease risk in GBA mutation carriers: information for genetic counseling , 2012, Genetics in Medicine.

[9]  J. Trojanowski,et al.  Mutations in COQ2 in familial and sporadic multiple-system atrophy. , 2013, The New England journal of medicine.

[10]  Ellen Sidransky,et al.  The link between the GBA gene and parkinsonism , 2012, The Lancet Neurology.

[11]  O. Tysnes,et al.  Number of CAG repeats in POLG1 and its association with Parkinson disease in the Norwegian population. , 2012, Mitochondrion.

[12]  S. Sawcer,et al.  Systematic Review and UK‐Based Study of PARK2 (parkin), PINK1, PARK7 (DJ‐1) and LRRK2 in early‐onset Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.

[13]  I. Mackenzie,et al.  Advances in understanding the molecular basis of frontotemporal dementia , 2012, Nature Reviews Neurology.

[14]  A. Singleton,et al.  The genetics and neuropathology of Parkinson’s disease , 2012, Acta Neuropathologica.

[15]  O. Levy,et al.  The neuropathology of genetic Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.

[16]  K. Marder,et al.  Cognitive performance of GBA mutation carriers with early-onset PD , 2012, Neurology.

[17]  Janel O. Johnson,et al.  Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study , 2012, The Lancet Neurology.

[18]  J. Aharon-Peretz,et al.  The LRRK2 G2019S mutation is associated with Parkinson disease and concomitant non-skin cancers , 2012, Neurology.

[19]  Rou-shayn Chen,et al.  PLA2G6 mutations in PARK14‐linked young‐onset parkinsonism and sporadic Parkinson's disease , 2012, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[20]  Nick C Fox,et al.  Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features , 2012, Alzheimer's & Dementia.

[21]  J. Holton,et al.  The neuropathology, pathophysiology and genetics of multiple system atrophy , 2012, Neuropathology and applied neurobiology.

[22]  C. Manzoni,et al.  LRRK2 and Human Disease: A Complicated Question or a Question of Complexes? , 2012, Science Signaling.

[23]  Vincenzo Bonifati,et al.  Autosomal recessive parkinsonism. , 2012, Parkinsonism & related disorders.

[24]  Aldo Quattrone,et al.  Role of sepiapterin reductase gene at the PARK3 locus in Parkinson's disease , 2011, Neurobiology of Aging.

[25]  Michael K. Hutchinson,et al.  Translation initiator EIF4G1 mutations in familial Parkinson disease. , 2011, American journal of human genetics.

[26]  Marc N. Offman,et al.  A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. , 2011, American journal of human genetics.

[27]  J. Ioannidis,et al.  A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease , 2011, Neurobiology of Aging.

[28]  M. Mancuso,et al.  POLG1-Related and other “Mitochondrial Parkinsonisms”: an Overview , 2011, Journal of Molecular Neuroscience.

[29]  Sébastien Ourselin,et al.  Distinct profiles of brain atrophy in frontotemporal lobar degeneration caused by progranulin and tau mutations☆ , 2010, NeuroImage.

[30]  S. Dumanis,et al.  Parkinson-related parkin reduces α-Synuclein phosphorylation in a gene transfer model , 2010, Molecular Neurodegeneration.

[31]  T. Hashimoto,et al.  Phenotypic spectrum of patients with PLA2G6 mutation and PARK14-linked parkinsonism , 2010, Neurology.

[32]  Yusuke Nakamura,et al.  Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease , 2009, Nature Genetics.

[33]  K. Marder,et al.  Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease. , 2009, Archives of neurology.

[34]  Sonja W. Scholz,et al.  Genome-Wide Association Study reveals genetic risk underlying Parkinson’s disease , 2009, Nature Genetics.

[35]  A. Brice,et al.  Parkinson's disease: from monogenic forms to genetic susceptibility factors. , 2009, Human molecular genetics.

[36]  J. Jankovic,et al.  Lrrk2 R1441G-related Parkinson’s disease: evidence of a common founding event in the seventh century in Northern Spain , 2009, neurogenetics.

[37]  M. Farrer,et al.  DCTN1 mutations in Perry syndrome , 2009, Nature Genetics.

[38]  E. Tolosa,et al.  Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study , 2008, The Lancet Neurology.

[39]  M. Ronaghi,et al.  Genome-wide linkage analysis of a Parkinsonian-pyramidal syndrome pedigree by 500 K SNP arrays. , 2008, American journal of human genetics.

[40]  P. Pietrini,et al.  Corticobasal Syndrome Associated With the A9D Progranulin Mutation , 2007, Journal of neuropathology and experimental neurology.

[41]  R. Marconi,et al.  ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease , 2007, Neurology.

[42]  K. Marder,et al.  Frequency of LRRK2 mutations in early- and late-onset Parkinson disease , 2006, Neurology.

[43]  A. Singleton,et al.  Genetics of Parkinson's disease and parkinsonism , 2006, Annals of neurology.

[44]  C. Duijn,et al.  Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21 , 2006, Nature.

[45]  S. Melquist,et al.  Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 , 2006, Nature.

[46]  Robert W. Taylor,et al.  Phenotypic spectrum associated with mutations of the mitochondrial polymerase γ gene. Commentary , 2006 .

[47]  Christine Klein,et al.  LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. , 2006, The New England journal of medicine.

[48]  M. Farrer,et al.  Linkage disequilibrium and association of MAPT H1 in Parkinson disease. , 2004, American journal of human genetics.

[49]  Janel O. Johnson,et al.  α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.

[50]  Hong Jiang,et al.  Mutations in NR4A2 associated with familial Parkinson disease , 2003, Nature Genetics.

[51]  T. Foroud,et al.  Genome screen to identify susceptibility genes for Parkinson disease in a sample without parkin mutations. , 2002, American journal of human genetics.

[52]  M N Rossor,et al.  Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype , 2001, Neurology.

[53]  M. Farrer,et al.  Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson’s disease , 1999, Neurology.

[54]  J W Langston,et al.  Parkinson disease in twins: an etiologic study. , 1999, JAMA.

[55]  A Klug,et al.  Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[56]  Ronald C. Petersen,et al.  Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.

[57]  G. Schellenberg,et al.  Tau is a candidate gene for chromosome 17 frontotemporal dementia , 1998, Annals of neurology.

[58]  M. Polymeropoulos,et al.  Mapping of a Gene for Parkinson's Disease to Chromosome 4q21-q23 , 1996, Science.

[59]  K. Marder,et al.  Risk of Parkinson's disease among first-degree relatives , 1996, Neurology.